Compounds > albendazole
Page last updated: 2024-10-22

albendazole and Anemia, Hemolytic

albendazole has been researched along with Anemia, Hemolytic in 1 studies

Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hogan, J1
Dehoux, L1
Niel, O1
Elenga, N1
Deschênes, G1
Dauger, S1

Other Studies

1 other study available for albendazole and Anemia, Hemolytic

ArticleYear
Hemolytic anemia and irreversible kidney and brain injuries after accidental intravenous injection of albendazole suspension in an infant.
    Clinical toxicology (Philadelphia, Pa.), 2016, Volume: 54, Issue:1

    Topics: Acute Kidney Injury; Albendazole; Anemia, Hemolytic; Antinematodal Agents; Ascaridida Infections; Ce

2016